SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures
DAVE 185.53-2.8%11:53 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ~digs who wrote (1732)11/8/2005 9:53:35 PM
From: ~digs  Read Replies (2) of 7944
 
[MKRS.OB] MIKROS SYS CORP › 0.20 -0.01 ( -4.76%)
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Mikros Systems Corporation engages in the research and development of electronic systems technology primarily for military applications in the United States. The company’s capabilities include technology management, electronic systems engineering and integration, radar systems engineering, combat/command, control, communications, computers and intelligence systems engineering, and communications engineering. It develops technology and products for military radio frequency and underwater data communications. The company is developing Adaptive Diagnostic Electronic Portable Testset, which would be used as a computer-aided alignment and maintenance tool.

[IMGN] IMMUNOGEN INC › 5.71 +0.33 ( +6.13%)
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
ImmunoGen, Inc. engages in the discovery and development of therapeutic monoclonal antibodies and treatments in the field of oncology in the United States and the United Kingdom. It develops novel, targeted therapeutics using its tumor-activated prodrug (TAP) technology, which uses monoclonal antibodies to deliver potent cell-killing agents. The company’s two leading product candidates include huN901-DM1 and huC242-DM4, which are in clinical testing stage. Its huN901-DM1 product candidate consists of the huN901 antibody, which binds to the CD56 antigen, a cytotoxic agent. The company’s second clinical TAP product candidate, huC242-DM4, consists of the humanized C242 monoclonal antibody with its cytotoxic agent attached and is in development for the treatment of colorectal, pancreatic, and other cancers. ImmunoGen also licenses its TAP technology to other biotechnology and pharmaceutical companies. ImmunoGen has collaborative partnerships with sanofi-aventis, Biogen Idec, Inc.; Boehringer Ingelheim International GmbH; Centocor, Inc.; Millennium Pharmaceuticals, Inc.; Abgenix, Inc.; Genentech, Inc.; and GlaxoSmithKline plc.

[TFR] TEFRON LTD ORD › 7.40 +0.32 ( +4.52%) .. n52wh
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Tefron, Ltd., together with its subsidiaries, engages in the design, manufacture, and sale of knitted intimate apparel, swim wear, and active wear for the health care industry. Its apparel products include knitted briefs, bras, tank tops, boxers, leggings, crop, T-shirts, nightwear, bodysuits, swim wear, beach wear, and active-wear. The company’s healthcare products include anti-embolism stockings and compression therapy systems; sterile wound dressings; and dressing retainers and net tubing designed to hold dressings in place without the use of adhesive tape.

[JLWT.OB] JANEL WORLD TRADE › 1.05 +0.1 ( +10.53%) .. n52wh
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Janel World Trade, Ltd., through its wholly owned subsidiaries, provides cargo transportation logistics management, including freight forwarding via air, ocean, and land-based carriers; customs brokerage services; and warehousing and distribution services worldwide. In addition, the company offers various related logistics services, such as freight consolidation, insurance, a direct client computer access interface, logistics planning, landed-cost calculations, in-house computer tracking, product repackaging, online shipment tracking, and electronic billing.

[PRPX] PORTEC RAIL PRODU › 12.11 +0.16 ( +1.34%)
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Portec Rail Products, Inc. engages in the manufacture, supply, and distribution of various railroad products. The company operates in four divisions: Railway Maintenance Products, Shipping Systems, 3094497 Nova Scotia Company (Canada), and Portec Rail Products (UK), Ltd. (Rail Products). The Railway Maintenance Products division manufactures and assembles track components and related products, friction management products, wayside data collection, and data management systems. It also provides services to railroads, transit systems, and railroad contractors, as well as distributes and resells purchased track components and lubricants manufactured by third parties. In addition, this division designs, manufactures, and provides wayside measurement and detection products, services, and support for railway transportation industry. The Shipping Systems division engineers and sells load securement systems to the railroad freight car market. The Canada division manufactures rail anchors and rail spikes, and assembles friction management products primarily for Canadian railroads. It also manufactures stick lubrication and application systems, and a liquid friction modifier. The Rail Products division sells friction management products and services to the United Kingdom passenger rail network. Its material handling business offers product lines, such as overhead and floor conveyor systems, racking systems, and mezzanine flooring systems primarily for the United Kingdom-based companies in the manufacturing, distribution, garment, and food industries.

update: [SPOP.OB] SPECTRUM ORGANICS › 0.71 +0.02 ( +2.90%) .. record volume
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G

update: [EZEN.OB] EZENIA INC › 2.73 +0.18 ( +7.06%)
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G

update: [PAM] PACIFIC CMA INC › 0.86 +0.09 ( +11.69%)
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G

update: [AIS] ANTARES PHARMA IN › 1.26 +0.07 ( +5.88%)
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext